N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification
- PMID: 2048223
- DOI: 10.1177/030089169107700205
N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification
Abstract
N-myc and c-myc amplification was investigated in 27 medulloblastomas. DNA was extracted from 19 formalin fixed and paraffin embedded tumors and from fresh frozen tumor tissue in 8 other cases. The results showed no evidence of amplification of N-myc oncogene and only 1 case had a 27 fold amplification of c-myc. Cytogenetically, this neoplasm presented numerous double minute chromosomes (DMs). Moreover, it had an unusual rapidly aggressive course with massive cerebrospinal fluid dissemination unresponsive to intrathecal chemotherapy. Our results indicate a low incidence of N-myc and c-myc gene amplification in medulloblastomas, suggesting that the oncogenic mechanism in these neoplasms is not closely related to DNA gene amplification. C-myc amplification, although not frequently observed, may however provide a growth advantage for medulloblastoma cells in vivo, favoring their rapid dissemination. Medulloblastomas with c-myc activation may represent a subgroup of tumors with a more aggressive behavior.
Similar articles
-
MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.Arch Pathol Lab Med. 2002 May;126(5):540-4. doi: 10.5858/2002-126-0540-MAMOAI. Arch Pathol Lab Med. 2002. PMID: 11958658
-
Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.Cancer Res. 1990 Apr 15;50(8):2347-50. Cancer Res. 1990. PMID: 2180567
-
Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):187-93. doi: 10.3171/ped.2004.100.2.0187. J Neurosurg. 2004. PMID: 14758948
-
Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature.Clin Neurol Neurosurg. 2000 Dec;102(4):203-209. doi: 10.1016/s0303-8467(00)00112-8. Clin Neurol Neurosurg. 2000. PMID: 11154805 Review.
-
Genetic alterations in glioma and medulloblastoma.Cancer Metastasis Rev. 1991 Dec;10(4):289-99. doi: 10.1007/BF00554791. Cancer Metastasis Rev. 1991. PMID: 1786630 Review.
Cited by
-
Molecular subgroups of medulloblastoma.Expert Rev Neurother. 2012 Jul;12(7):871-84. doi: 10.1586/ern.12.66. Expert Rev Neurother. 2012. PMID: 22853794 Free PMC article. Review.
-
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation.Genes Dev. 2002 Oct 15;16(20):2699-712. doi: 10.1101/gad.1021202. Genes Dev. 2002. PMID: 12381668 Free PMC article.
-
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.PLoS One. 2008 Aug 28;3(8):e3088. doi: 10.1371/journal.pone.0003088. PLoS One. 2008. PMID: 18769486 Free PMC article.
-
Molecular pathogenesis of childhood brain tumors.J Neurooncol. 2004 Nov;70(2):203-15. doi: 10.1007/s11060-004-2750-7. J Neurooncol. 2004. PMID: 15674478 Review.
-
Comprehensive identification of a two-genesignature as a novel potential prognostic model for patients with medulloblastoma.Am J Transl Res. 2020 May 15;12(5):1600-1613. eCollection 2020. Am J Transl Res. 2020. PMID: 32509164 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources